A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis
We have established a robust protein-related signature capable of accurately forecasting prognosis as well as immunotherapy outcomes for NPC patients. Moreover, DUSP14 emerged as a potential therapeutic target due to its strong association with patient prognosis in nasopharyngeal carcinoma.
Authors
- Lixin Zhu (ORCID: https://orcid.org/0000-0001-7904-1769)
- Yuan Liu (ORCID: https://orcid.org/0000-0003-4887-907X)
- Yanyan Han (ORCID: https://orcid.org/0009-0007-2307-0094)
- Wenliang Duan
- Lijing Peng (ORCID: https://orcid.org/0000-0002-3033-4322)
- Zhenke Huang
- Yun-xiang Da
- Xinxin Shan
Institutions
- Shanghai University of Medicine and Health Sciences (CN)
- Punan Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37897
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84